Cargando…

Glaucoma and amyotrophic lateral sclerosis, two kindred diseases?

Detalles Bibliográficos
Autor principal:	Carreras, Francisco Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090839/ https://www.ncbi.nlm.nih.gov/pubmed/27857740 http://dx.doi.org/10.4103/1673-5374.191211

Ejemplares similares

Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis
por: Riancho, Javier, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis disease burden: doing better at getting better
por: Volonté, Cinzia, et al.
Publicado: (2022)

Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet
por: Lerskiatiphanich, Titaya, et al.
Publicado: (2022)

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
por: Ruiz-López, Francisco José, et al.
Publicado: (2016)

Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective
por: Tang, Bor Luen
Publicado: (2017)

Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement
por: Ramírez, Ana I., et al.
Publicado: (2021)

Fibrosis as a common trait in amyotrophic lateral sclerosis tissues
por: Apolloni, Savina, et al.
Publicado: (2021)

Complement: a global immunometabolic regulator in amyotrophic lateral sclerosis
por: Lo, Martin W., et al.
Publicado: (2020)

Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
por: Toth, Reka P., et al.
Publicado: (2018)

P2X7 receptor antagonism in amyotrophic lateral sclerosis
por: Sluyter, Ronald, et al.
Publicado: (2017)

Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration
por: Oliveira, Danyllo, et al.
Publicado: (2021)

State-of-art modelling of inflammatory astrocyte-synapse interactions in injury and amyotrophic lateral sclerosis
por: Lakatos, András
Publicado: (2017)

Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosis
por: Bose, Poulomee
Publicado: (2019)

The important functional role of TDP-43 plays in amyotrophic lateral sclerosis-frontotemporal dementia
por: Chen, Liam
Publicado: (2020)

Mending the broken in amyotrophic lateral sclerosis: DNA damage and repair in motor neuron degeneration
por: Kim, Byung Woo, et al.
Publicado: (2020)

Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis?
por: Chisholm, Christen G., et al.
Publicado: (2022)

Understanding metabolic flexibility: a potential key to unlocking metabolic therapies in amyotrophic lateral sclerosis?
por: Allen, Scott P.
Publicado: (2020)

Degenerative and regenerative processes in amyotrophic lateral sclerosis: motor reserve, adaptation and putative compensatory changes
por: Bede, Peter, et al.
Publicado: (2020)

Chemically oligomerizable TDP-43: a novel chemogenetic tool for studying the pathophysiology of amyotrophic lateral sclerosis
por: Kanekura, Kohsuke, et al.
Publicado: (2022)

Fused in sarcoma-amyotrophic lateral sclerosis as a novel member of DNA single strand break diseases with pure neurological phenotypes
por: Naumann, Marcel, et al.
Publicado: (2020)

Combination of novel RNA sequencing and sophisticated network modeling to reveal a common denominator in amyotrophic lateral sclerosis?
por: Dash, Banaja P., et al.
Publicado: (2023)

Adipose-derived stem cell conditioned medium for the treatment of amyotrophic lateral sclerosis: pre-clinical evidence and potential for clinical application
por: Walker, Chandler L.
Publicado: (2019)

Neuromuscular junction mitochondrial enrichment: a “double-edged sword” underlying the selective motor neuron vulnerability in amyotrophic lateral sclerosis
por: Altman, Topaz, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Diffusion tensor imaging as a tool to detect presymptomatic axonal degeneration in a preclinical spinal cord model of amyotrophic lateral sclerosis
por: Gatto, Rodolfo Gabriel
Publicado: (2018)

Muscle secretion of toxic factors, regulated by miR126-5p, facilitates motor neuron degeneration in amyotrophic lateral sclerosis
por: Maimon, Roy, et al.
Publicado: (2019)

Current status and future directions of amyotrophic lateral sclerosis research in Africa: a perspective
por: Aderinto, Nicholas, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Bronchitis, and Kindred Diseases
Publicado: (1854)

Bronchitis, and Kindred Diseases
por: Hall, W. W.
Publicado: (1868)

Bronchitis, and Kindred Diseases
por: Hall, W. W.
Publicado: (1864)

Bronchitis, and Kindred Diseases
por: Hall, W. W.
Publicado: (1867)

Predicting disease progression in amyotrophic lateral sclerosis
por: Taylor, Albert A., et al.
Publicado: (2016)

Quantifying Disease Progression in Amyotrophic Lateral Sclerosis
por: Simon, Neil G, et al.
Publicado: (2014)

Amyotrophic Lateral Sclerosis as a Systemic Disease
por: Moresi, Viviana
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3dacelriohq6acbs3i9kk3h2nc